2024-10-26 18:18:09
Alterity Therapeutics Announces Publication Demonstrating that ATH434 is Neuroprotective in Animal Model of Parkinsonian Disorder in the Journal of Parkinson's Disease
Corporate/ 2023-07-24
Alterity Therapeutics Announces Publicat...

MELBOURNE,Australia,Jan. 28,2022--Alterity Therapeutics (ASX: ATH,NASDAQ: ATHE) ("Alterity" or "the Company"),a biotechn...

"Don't forget leprosy" campaign gathers pace as World Leprosy Day approaches
Health/ 2023-07-22
"Don't forget leprosy" ca...

TOKYO,Jan. 28,2022-- Sasakawa Leprosy (Hansen\'s Disease) Initiative is collaborating with 32 organizations from 13 countries to promote the...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release